# Al18F-NOTA-LM3 PET/CT in Patients With Pheochromocytoma and Paraganglioma

> **NCT07288931** · NA · RECRUITING · sponsor: **Peking Union Medical College Hospital** · enrollment: 40 (estimated)

## Conditions studied

- Pheochromocytoma/Paraganglioma (PPGL)

## Interventions

- **DRUG:** Diagnostic Test: Al18F-NOTA-LM3
- **DRUG:** Diagnostic Test: 68Ga-DOTATATE

## Key facts

- **NCT ID:** NCT07288931
- **Lead sponsor:** Peking Union Medical College Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-08-06
- **Primary completion:** 2025-12-31
- **Final completion:** 2026-03-01
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2025-12-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07288931

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07288931, "Al18F-NOTA-LM3 PET/CT in Patients With Pheochromocytoma and Paraganglioma". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT07288931. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*